|
Complex Regional Pain Syndromes
|
D020918 |
[Conditions characterized by pain involving an extremity or other body region, HYPERESTHESIA, and localized autonomic dysfunction following injury to soft tissue or nerve. The pain is usually associated with ERYTHEMA; SKIN TEMPERATURE changes, abnormal sudomotor activity (i.e., changes in sweating due to altered sympathetic innervation) or edema. The degree of pain and other manifestations is out of proportion to that expected from the inciting event. Two subtypes of this condition have been described: type I; (REFLEX SYMPATHETIC DYSTROPHY) and type II; (CAUSALGIA). (From Pain 1995 Oct;63(1):127-33)
] |
|
BRCA2 Protein
|
D12.776.313.249 |
|
|
Prosthesis Implantation
|
D019919 |
[Surgical insertion of a prosthesis.
] |
|
Sleep Disorders, Intrinsic
|
D020919 |
[Dyssomnias (i.e., insomnias or hypersomnias) associated with dysfunction of internal sleep mechanisms or secondary to a sleep-related medical disorder (e.g., sleep apnea, post-traumatic sleep disorders, etc.). (From Thorpy, Sleep Disorders Medicine, 1994, p187)
] |
|
Conotoxins
|
D020916 |
[Peptide neurotoxins from the marine fish-hunting snails of the genus CONUS. They contain 13 to 29 amino acids which are strongly basic and are highly cross-linked by disulfide bonds. There are three types of conotoxins, omega-, alpha-, and mu-. OMEGA-CONOTOXINS inhibit voltage-activated entry of calcium into the presynaptic membrane and therefore the release of ACETYLCHOLINE. Alpha-conotoxins inhibit the postsynaptic acetylcholine receptor. Mu-conotoxins prevent the generation of muscle action potentials. (From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed)
] |
|
Receptor, trkA
|
D020917 |
[A protein-tyrosine kinase receptor that is specific for NERVE GROWTH FACTOR; NEUROTROPHIN 3; neurotrophin 4, neurotrophin 5. It plays a crucial role in pain sensation and thermoregulation in humans. Gene mutations that cause loss of receptor function are associated with CONGENITAL INSENSITIVITY TO PAIN WITH ANHIDROSIS, while gene rearrangements that activate the protein-tyrosine kinase function are associated with tumorigenesis.
] |
|
Planococcus Insect
|
B01.050.500.131.617.412.600 |
|
|
Pyrenes
|
D04.615.799 |
|
|
Polycyclic Aromatic Hydrocarbons
|
D04.615 |
|
|
Taq Polymerase
|
D019914 |
[A heat stable DNA-DIRECTED DNA POLYMERASE from the bacteria Thermus aquaticus. It is widely used for the amplification of genes through the process of POLYMERASE CHAIN REACTION. EC 2.7.7.-.
] |
|
Myopathies, Structural, Congenital
|
D020914 |
[A heterogeneous group of diseases characterized by the early onset of hypotonia, developmental delay of motor skills, non-progressive weakness. Each of these disorders is associated with a specific histologic muscle fiber abnormality.
] |
|
DNA Primase
|
D019915 |
[A single-stranded DNA-dependent RNA polymerase that functions to initiate, or prime, DNA synthesis by synthesizing oligoribonucleotide primers. EC 2.7.7.-.
] |
|
Light Coagulation
|
E04.540.630 |
|
|
Korsakoff Syndrome
|
D020915 |
[An acquired cognitive disorder characterized by inattentiveness and the inability to form short term memories. This disorder is frequently associated with chronic ALCOHOLISM; but it may also result from dietary deficiencies; CRANIOCEREBRAL TRAUMA; NEOPLASMS; CEREBROVASCULAR DISORDERS; ENCEPHALITIS; EPILEPSY; and other conditions. (Adams et al., Principles of Neurology, 6th ed, p1139)
] |
|
Choline-Phosphate Cytidylyltransferase
|
D019916 |
[An enzyme that catalyzes the transfer of cytidylate (CMP) to choline phosphate to form CDPcholine. It is the rate-limiting enzyme in the choline pathway for the biosynthesis of phosphatidylcholine. Its activity is increased by glucocorticoids. EC 2.7.7.15.
] |
|
Moclobemide
|
D020912 |
[A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
] |
|
Blood Vessel Prosthesis Implantation
|
D019917 |
[Surgical insertion of BLOOD VESSEL PROSTHESES to repair injured or diseased blood vessels.
] |
|
Microplastics
|
D25.720.716.294 |
|
|
Perindopril
|
D020913 |
[An angiotensin-converting enzyme inhibitor. It is used in patients with hypertension and heart failure.
] |
|
Mycobacterium marinum
|
D019910 |
[A moderate-growing, photochromogenic species found in aquariums, diseased fish, and swimming pools. It is the cause of cutaneous lesions and granulomas (swimming pool granuloma) in humans. (Dorland, 28th ed)
] |
